🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Rowa Pharmaceuticals Limited, — Licensed Medicines

82 medicines held by Rowa Pharmaceuticals Limited, on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 82 products held by Rowa Pharmaceuticals Limited,
MedicineActive substanceLicence holderStatus
Abiraterone Rowa 500 mg Film-coated tablets
PA0074/092/001
Abiraterone acetate Rowa Pharmaceuticals Limited, Marketed
Apixaban Rowa 2.5 mg Film-coated tablets
PA0074/098/001
Apixaban Rowa Pharmaceuticals Limited, Not marketed
Apixaban Rowa 5 mg Film-coated tablets
PA0074/098/002
Apixaban Rowa Pharmaceuticals Limited, Not marketed
Atorvastatin Rowa 10 mg film-coated tablets
PA0074/079/001
Atorvastatin Rowa Pharmaceuticals Limited, Marketed
Atorvastatin Rowa 20 mg film-coated tablets
PA0074/079/002
Atorvastatin Rowa Pharmaceuticals Limited, Marketed
Atorvastatin Rowa 40 mg film-coated tablets
PA0074/079/003
Atorvastatin Rowa Pharmaceuticals Limited, Marketed
Atorvastatin Rowa 80 mg film-coated tablets
PA0074/079/004
Atorvastatin Rowa Pharmaceuticals Limited, Marketed
Brupro 200mg Film-coated tablets
PA0074/067/001
Ibuprofen Rowa Pharmaceuticals Limited, Marketed
Brupro Cold & Flu 200 mg/30 mg film-coated tablets
PA0074/067/006
Ibuprofen, PSEUDOEPHEDRINE HYDROCHLORIDE Rowa Pharmaceuticals Limited, Marketed
Brupro for Children 100 mg/5 ml oral suspension
PA0074/067/004
Ibuprofen Rowa Pharmaceuticals Limited, Marketed
Brupro for Children Six Plus 200 mg/5 ml oral suspension
PA0074/067/005
Ibuprofen Rowa Pharmaceuticals Limited, Marketed
Brupro Max 400mg Film-coated tablets
PA0074/067/002
Ibuprofen Rowa Pharmaceuticals Limited Marketed
Brupro Rx 600mg Film-coated tablets
PA0074/067/003
Ibuprofen Rowa Pharmaceuticals Limited Not marketed
Carbosan 2% w/w Gel
PA0074/011/001
CARBENOXOLONE SODIUM Rowa Pharmaceuticals Limited Marketed
Dabigatran etexilate Rowa 110 mg hard capsules
PA0074/095/001
Dabigatran etexilate mesilate Rowa Pharmaceuticals Limited, Not marketed
Dabigatran etexilate Rowa 150 mg hard capsules
PA0074/095/002
Dabigatran etexilate mesilate Rowa Pharmaceuticals Limited, Not marketed
Dutasteride Rowa 0.5 mg soft capsules
PA0074/076/002
Dutasteride Rowa Pharmaceuticals Limited, Marketed
Dutasteride/Tamsulosin Rowa 0.5 mg/0.4 mg hard capsules.
PA0074/076/001
Tamsulosin hydrochloride, Dutasteride Rowa Pharmaceuticals Limited, Marketed
Ezetimibe Rowa 10 mg tablets
PA0074/074/001
Ezetimibe Rowa Pharmaceuticals Limited, Marketed
Fampridine Rowa 10 mg prolonged-release tablets
PA0074/087/001
Fampridine Rowa Pharmaceuticals Limited Not marketed
Febuxostat Rowa 120 mg film-coated tablets
PA0074/085/002
Febuxostat Rowa Pharmaceuticals Limited,
Febuxostat Rowa 80 mg film-coated tablets
PA0074/085/001
Febuxostat Rowa Pharmaceuticals Limited,
Fesoterodine Rowa 4 mg prolonged-release tablets
PA0074/091/001
Fesoterodine fumarate Rowa Pharmaceuticals Limited, Not marketed
Fesoterodine Rowa 8 mg prolonged-release tablets
PA0074/091/002
Fesoterodine fumarate Rowa Pharmaceuticals Limited, Not marketed
Fexo Allergy Relief 120 mg film-coated tablets
PA0074/096/001
Fexofenadine hydrochloride Rowa Pharmaceuticals Limited, Marketed
Fingolimod 0.5 mg hard capsules
PA0074/086/001
Fingolimod Rowa Pharmaceuticals Limited, Not marketed
Irbesartan Rowa 150 mg tablets
PA0074/080/002
Irbesartan Rowa Pharmaceuticals Limited Marketed
Irbesartan Rowa 300 mg tablets
PA0074/080/003
Irbesartan Rowa Pharmaceuticals Limited Marketed
Irbesartan Rowa 75 mg tablets
PA0074/080/001
Irbesartan Rowa Pharmaceuticals Limited Marketed
Losartan Rowa 100mg film-coated tablets
PA0074/082/003
Losartan potassium Rowa Pharmaceuticals Limited, Marketed
Losartan Rowa 50mg film-coated tablets
PA0074/082/002
Losartan potassium Rowa Pharmaceuticals Limited, Marketed
Lotanos Comp 100 mg/25 mg film-coated tablets
PA0074/072/002
Losartan potassium, Hydrochlorothiazide Rowa Pharmaceuticals Limited, Marketed
Lotanos Comp 50 mg/12.5 mg film-coated tablets
PA0074/072/001
Losartan potassium, Hydrochlorothiazide Rowa Pharmaceuticals Limited, Marketed
Magnesium Verla 5 mmol granules for oral solution
PA0074/062/001
Magnesium Rowa Pharmaceuticals Limited Marketed
MEFAC 250 mg hard capsules
PA0074/015/001
Mefenamic acid Rowa Pharmaceuticals Limited, Not marketed
MEFAC 500 mg Film-coated tablets
PA0074/015/002
Mefenamic acid Rowa Pharmaceuticals Limited Marketed
Midazolam Rowa 10 mg oromucosal solution
PA0074/099/004
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 2.5 mg oromucosal solution
PA0074/099/001
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 5 mg oromucosal solution
PA0074/099/002
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 7.5 mg oromucosal solution
PA0074/099/003
Midazolam Rowa Pharmaceuticals Limited, Marketed
Omeprazole Rowa 20 mg Gastro-resistant Capsules, hard
PA0074/075/002
Omeprazole Rowa Pharmaceuticals Limited, Marketed
Omeprazole Rowa 40 mg Gastro-Resistant Capsules, hard
PA0074/075/003
Omeprazole Rowa Pharmaceuticals Limited, Marketed
Pantup 20 mg gastro-resistant tablets
PA0074/069/001
Pantoprazole Rowa Pharmaceuticals Limited, Not marketed
Pantup 40 mg gastro-resistant tablets
PA0074/069/002
Pantoprazole Rowa Pharmaceuticals Limited, Not marketed
Razole 10 mg Gastro-resistant tablets
PA0074/073/001
Rabeprazole sodium Rowa Pharmaceuticals Limited Not marketed
Razole 20 mg Gastro-resistant tablets
PA0074/073/002
Rabeprazole sodium Rowa Pharmaceuticals Limited Not marketed
Rivaroxaban Rowa 10 mg film-coated tablets
PA0074/097/001
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rivaroxaban Rowa 15 mg film-coated tablets
PA0074/097/002
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rivaroxaban Rowa 20 mg film-coated tablets
PA0074/097/003
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rosuvastatin Rowa 10 mg film-coated tablets
PA0074/093/002
Rosuvastatin Rowa Pharmaceuticals Limited, Marketed
1 2

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.